Swiss-Based Medtech VC Fund Launches STO Platform for its Security Token
BlueOcean Ventures II, a tokenized medtech venture capital fund backed by Swiss-based VC firm BlueOcean Ventures, recently announced the launch of SwissVCToken, the security token offering (STO) platform developed for the sale of the fund’s BOV Token, according to a press release seen by Cryptovest.
BlueOcean Ventures II is the second fund of the VC firm. It focuses on startups and companies that manufacture and/or distribute medical devices and life science products. The fund aims to support innovations that increase quality of life and improve health.
The VC fund will use the STO platform to sell its BOV token, which is backed by real-world assets and the price of which derives from the value of the companies included in the fund’s portfolio. The BOV Token will enable professional and accredited investors to indirectly generate investment returns from the fund’s portfolio startups at their early stage. So far, BlueOcean Ventures II invested in five medtech startups: Ava, Volumina Medical, Rheon Medical, Luciole Medical, and Abionic. Soon, the fund will add more firms, aiming to reach up to 12 companies. The fund is allowing its investors to buy the tokens with both cryptocurrency (BTC and ETH) and fiat money (CHF and USD).
Statement from Emmanuel de Watteville
Emmanuel de Watteville, general partner and co-founder of BlueOcean Ventures ll, commented:
“At BlueOcean, we feel confident in our mission to enable outstanding medtech startups to develop novel devices and treatments. The tokenization of venture capital enables a new range of qualified investors for the first time to participate in this promising asset class.”
Target Market and Investment Focus
The VC fund targets medical device and diagnostics startups from Switzerland and the EU. It also shows interest in companies operating in the life sciences, digital health and nanotechnology markets.
Investment in Volumina Medical
Recently, BlueOcean Ventures II announced its lead investment in Swiss-based startup Volumina Medical, which is developing tissue reconstruction solutions for the reconstructive and plastic surgery sectors. The startup closed its July 2018 seed funding round by raising the equivalent of $3.1 million. BlueOcean Ventures ll led the financing round, which was joined by Zürcher Kantonal Bank and other private investors.
“BlueOcean Ventures ll is proud to lead Volumina Medical’s financing seed round and is confident Volumina will develop products that will aid the reconstructive and cosmetic surgery markets for years to come.”
“There is a significant need for state-of-the-art technology that provides sufficient, long-lasting results, and we’re looking forward to the tools Volumina will produce that will contribute to the medtech industry for the better.”